DRD3 and glioblastoma: Treatment of NHAs or neurons with several DRD3 antagonists had no growth inhibitory effects (Fig 2A–2D), and growth inhibition was significantly lower in non-tumorigenic cells in comparison to GBM cells for the majority of DRD3 antagonists tested (Fig 2).